The Institute for Pharmacology and Preventive Medicine
The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.
Recent Activity / Publications in press
Steeds R, Potter A, Mangat N, Fröhlich M, Deutsch C, Bramlage P, Thoenes M. Community-based aortic stenosis detection: Clinical and echocardiographic screening during influenza vaccination. Open Heart 2021
Bramlage P, Lanzinger S, Tittel S, Hess E, Fahrner S, Heyer CHJ, Friebe M, Buschmann I, Danne T, Seufert J, Holl RWH. Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis. BMC Nephrology 2021
Zemmrich C, Bramlage P, Hillmeister P, Scirovic M, Buschmann I. Risk factor management in non-metropolitan patients with coronary and peripheral artery disease – a prospective, multi-center, quality improvement strategy. VHRM 2021
Grünewald M, Häge E, Lehnert S, Maier C, Schimke A, Bramlage P, Güth M. Prophylactic anticoagulation with intermediate-dose certoparin in vascular-risk pregnancies – the PACER-VARP registry. CATH 2021
van Mark G, Tittel SR, Welp R, Gloyer J, Sziegoleit S, Barion R, Jehle PM, Erath D, Bramlage P, Lanzinger S. The DIVE/DPV registries: Benefits and risks of analogue insulin use in individuals 75 years and older with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care 2021.
Steffens D, Bramlage P, Müller J, Dorn C, Paar WD, Scheef C, Kasner M, Rauch-Kröhnert U. Intensified Lipid-Lowering Treatment with Alirocumab in Patients with Coronary Heart Disease. Open Heart 2021.
Studencan M, Pella D, Bramlage P, Kaszasova E. Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in Slovakia. Archives of Medical Science 2021.
PubMed listed Publications